Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Standardized extracts modified allergens--allergoids.

× No keyword cloud information.

25 in total

1. Studies on "allergoids" prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component.

Authors: D G Marsh; L M Lichtenstein; D H Campbell
Journal: Immunology Date: 1970-05 Impact factor: 7.397

2. Allergen nomenclature.

Authors: D G Marsh; L Goodfriend; T P King; H Lowenstein; T A Platts-Mills
Journal: Bull World Health Organ Date: 1986 Impact factor: 9.408

Review 3. Clinical and immunologic aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis and/or allergic asthma.

Authors: R E Rocklin
Journal: J Allergy Clin Immunol Date: 1983-10 Impact factor: 10.793

4. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.

Authors: P S Norman; L M Lichtenstein; A Kagey-Sobotka; D G Marsh
Journal: J Allergy Clin Immunol Date: 1982-10 Impact factor: 10.793

Review 5. Immunotherapy.

Authors: P S Norman
Journal: Prog Allergy Date: 1982

6. Variations in T cell subsets during hyposensitization of grass-sensitive patients with formaldehyde modified extracts: allergoids.

Authors: F Anfosso; G Alcaraz; D Vervloet; J Charpin
Journal: Allergy Date: 1982-11 Impact factor: 13.146

7. Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever.

Authors: P S Norman; L M Lichtenstein; D G Marsh
Journal: J Allergy Clin Immunol Date: 1981-12 Impact factor: 10.793

8. Studies of chemically modified honeybee venom. I. Biochemical, toxicologic and immunologic characterization.

Authors: U Mueller; R Reisman; W Elliott; R Steger; S Walsh; J Wypych; C Arbesman
Journal: Int Arch Allergy Appl Immunol Date: 1982

9. Comparison of histamine release assay and RAST inhibition as tools for allergen extract standardization.

Authors: H J Maasch; B Fischer; R Wahl; U Wahn
Journal: Int Arch Allergy Appl Immunol Date: 1984

10. Enzyme determination and RAST inhibition assays for orchard grass (Dactylis glomerata): a comparison of commericial pollen extracts.

Authors: J Bousquet; J P Marty; Y Coulomb; M Robinet-Levy; P Cour; F B Michel
Journal: Ann Allergy Date: 1978-09

8 in total

Review 1. Immunotherapy for allergies and asthma: present and future.

Authors: Shyam S Mohapatra; Momina Qazi; Gary Hellermann
Journal: Curr Opin Pharmacol Date: 2010-06-21 Impact factor: 5.547

Review 2. [Cluster immunotherapy in allergic rhinoconjunctivitis: review of a new therapeutic approach].

Authors: O Pfaar; L Klimek
Journal: Hautarzt Date: 2006-10 Impact factor: 0.751

3. Actual therapeutic management of allergic and hyperreactive nasal disorders.

Authors: Claudia Rudack
Journal: GMS Curr Top Otorhinolaryngol Head Neck Surg Date: 2004-12-28

Review 4. Nanomaterials in the Context of Type 2 Immune Responses-Fears and Potentials.

Authors: Martin Himly; Robert Mills-Goodlet; Mark Geppert; Albert Duschl
Journal: Front Immunol Date: 2017-04-25 Impact factor: 7.561

5. Therapeutic vaccines for allergic disease.

Authors: Danuta Gutowska-Owsiak; Graham S Ogg
Journal: NPJ Vaccines Date: 2017-05-08 Impact factor: 7.344

6. Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma.

Authors: Giovanni Traina; Alberto Martelli; Salvatore Barberi; Amelia Licari; Gian Luigi Marseglia; Maria Angela Tosca; Giorgio Ciprandi
Journal: Acta Biomed Date: 2021-02-04

7. 13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation.

Authors: Andreas Distler; Debbie Pappelendam
Journal: Allergo J Int Date: 2015-12-17

8. An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial.

Authors: A M Chaker; B Al-Kadah; U Luther; U Neumann; M Wagenmann
Journal: Clin Transl Allergy Date: 2016-02-02 Impact factor: 5.871

8 in total